Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Opus Genetics (IRD) Reiterated at Overweight by Cantor Fitzgerald on Positive Update
-
Form 8-K Cantor Fitzgerald Income For: Jul 07
-
Willis Towers Watson (WTW) PT Raised to $344 at Cantor Fitzgerald on Better Q2 Setup
-
Ryan Specialty Group (RYAN) PT Raised to $34 at Cantor Fitzgerald as Shares Rally
-
RenaissanceRe Holdings (RNR) PT Raised to $354 at Cantor Fitzgerald on EPS Estimate Raise
-
Everest Group (EG) PT Raised to $390 at Cantor Fitzgerald on Likely 'Lighter Catastrophes'
-
Arch Capital (ACGL) PT Raised to $102 at Cantor Fitzgerald on Raised Estimates
-
W.R. Berkley (WRB) PT Raised to $74 at Cantor Fitzgerald on Stable Underlying Margins
-
Chubb Corporation (CB) PT Raised to $337 at Cantor Fitzgerald: 'Remains Well-Positioned'
-
Chubb Corporation (CB) PT Raised to $337 at Cantor Fitzgerald: 'Remains Well-Positioned'
-
Travelers (TRV) PT Raised to $360 at Cantor Fitzgerald on Evading Margin Deterioration
-
Cantor Fitzgerald Starts HCI Group (HCI) at Overweight
-
Cantor Fitzgerald Starts Merlin Labs (MRLN) at Overweight
-
Cantor Fitzgerald Starts Velo3D (VELO) at Overweight
-
Cantor Fitzgerald Upgrades American International Group (AIG) to Overweight
-
Cantor Equity Partners I, Inc. and Bitcoin Standard Treasury Company Provide Update on Proposed Business Combination
-
ON Semiconductor (ON) Reiterated at Neutral by Cantor Fitzgerald: Setup Positive
-
NXP Semiconductors NV (NXPI) Reiterated at Overweight by Cantor Fitzgerald: 'Best Value Play'
-
Microchip Technology (MCHP) Reiterated at Overweight by Cantor Fitzgerald on Likely Beat, Raise
-
Vera Therapeutics (VERA) Reiterated at Overweight by Cantor Fitzgerald on Trutakna Approval
-
DigitalOcean (DOCN) Reiterated at Overweight by Cantor Fitzgerald on Q2 Pre-Announcement
-
MasTec (MTZ) Reiterated at Overweight by Cantor Fitzgerald as Acquisition Agreement Announced
-
Alumis (ALMS) Reiterated at Overweight by Cantor Fitzgerald Ahead of Phase 2b SLE Readout
-
Analog Devices (ADI) Reiterated at Overweight by Cantor Fitzgerald on Likely Upside
-
Cantor Fitzgerald Assumes EyePoint Inc. (EYPT) at Overweight
-
Cantor Fitzgerald Starts Immuneering Corporation (IMRX) at Overweight
-
Form 8-K Cantor Fitzgerald Income For: Jul 07
-
Humana (HUM) PT Raised to $300 at Cantor Fitzgerald as Q/Q Enrollment Grows
-
HCA Healthcare Inc (HCA) PT Lowered to $528 at Cantor Fitzgerald Amid Difficult Setup
-
Elevance (ELV) PT Raised to $450 at Cantor Fitzgerald: Medicaid Cost Deterioration Unlikely
-
CVS Health (CVS) PT Raised to $110 at Cantor Fitzgerald Post Checks
-
Centene (CNC) PT Raised to $75 at Cantor Fitzgerald After Management Call, Checks
-
Capricor Therapeutics (CAPR) Reiterates Overweight Rating Ahead of Upcoming PDUFA
-
Vertex (VRTX) Reiterated at Overweight by Cantor Fitzgerald; Crinetics Acquisition Announced
-
Cantor Fitzgerald Downgrades Crinetics (CRNX) to Neutral
-
Form N-CSRS Cantor Fitzgerald Commod For: Apr 30
-
Meridian3 Industrials closes $201.25M IPO on Nasdaq
-
Meridian3 Industrials Acquisition Corp Announces Closing of $201.25 Million Initial Public Offering
-
Satellogic (SATL) Reiterated at Overweight by Cantor Fitzgerald: Partnering With SpaceKnow
-
Intuitive Machines (LUNR) Reiterated at Overweight by Cantor Fitzgerald on 6th CLPS Contract
-
Centene (CNC) Reiterated at Overweight by Cantor Fitzgerald as State Enrollment Declines
-
Humana (HUM) Reiterated at Neutral by Cantor Fitzgerald: Positive on Medicaid Exposure
-
Amgen (AMGN) Reiterated at Neutral by Cantor Fitzgerald: Q2 Beat Expected
-
Regeneron Pharma (REGN) PT Lowered to $750 at Cantor Fitzgerald on Negative Eylea Optics
-
Eli Lilly (LLY) PT Raised to $1,350 at Cantor Fitzgerald as Strong Q2 Results Likely
-
Abbvie (ABBV) PT Raised to $265 at Cantor Fitzgerald: Broadly Strong Q2 Results Expected
-
Cantor Fitzgerald Meets With Strategy (MSTR): 'Michael Saylor gave us a deeper, more nuanced understanding of the challenges faced by the company'
-
Osprey Acquisition Corp. III raises $300M in Nasdaq IPO
-
Osprey Acquisition Corp. III Completes $300.15 Million Initial Public Offering
-
Cantor Fitzgerald Reiterates Neutral Rating on Lucid Group Inc. (LCID)

